NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT05580887 2022-10-14Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer PatientsMoscow Clinical Scientific CenterUnknown35 enrolled
NCT01803282 2020-06-02Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid TumorsGilead SciencesPhase 1 Completed236 enrolled 21 charts
NCT00002854 2015-08-26High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerCity of Hope Medical CenterPhase 1 Completed33 enrolled
NCT00667641 2011-05-10Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsRutgers, The State University of New JerseyPhase 1 Completed16 enrolled